Get started
Work

Supplementary Table S5 from Characteristics of a CCL21 Gene–Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non–Small Cell Lung Cancer

Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table S5. Differentially expressed genes in CCL21-DC vaccines from healthy donors vs patients.
DOI: 10.1158/1535-7163.28342195
Authors: Michael S. Oh, Camelia Dumitras, Ramin Salehi-Rad, Linh M. Tran, Kostyantyn Krysan, Raymond J. Lim, Zhe Jing, Shahed Tappuni, Aaron Lisberg, Edward B. Garon, Steven M. Dubinett, Bin Liu
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4407145995
Cites:
Cited by:
Related to: 10